RS Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$572K Hold
3,758
0.01% 338
2016
Q1
$563K Hold
3,758
0.01% 337
2015
Q4
$610K Sell
3,758
-339
-8% -$53.3K 0.01% 306
2015
Q3
$567K Buy
4,097
+307
+8% +$48.4K 0.01% 317
2015
Q2
$582K Hold
3,790
0.01% 330
2015
Q1
$606K Sell
3,790
-230
-6% -$36.2K 0.01% 332
2014
Q4
$640K Buy
4,020
+180
+5% +$28K 0.01% 337
2014
Q3
$539K Hold
3,840
0.01% 353
2014
Q2
$455K Hold
3,840
﹤0.01% 357
2014
Q1
$474K Buy
+3,840
New +$466K ﹤0.01% 356

Other funds holding AMGN

RS Investment Management's AMGN Position: Q2 2016 in Review

RS Investment Management held its Amgen (AMGN) position steady in Q2 2016 at 3,758 shares worth $572K. The position accounts for 0.01% of the portfolio, ranked #338.

RS Investment Management first reported a position in AMGN in Q1 2014 and has held it in 10 quarters since. The position peaked at $640K in Q4 2014. 1,473 funds tracked by Wall St. Rank hold AMGN as of Q2 2016.

  • RS Investment Management held 3,758 shares of Amgen worth $572K as of Q2 2016.
  • RS Investment Management left its Amgen share count unchanged in Q2 2016.
  • Amgen made up 0.01% of RS Investment Management's portfolio in Q2 2016, its #338 holding.
  • RS Investment Management first reported a position in Amgen in Q1 2014 and has held it in 10 quarters since.
  • RS Investment Management's Amgen position peaked at $640K in Q4 2014.
  • 1,473 funds tracked by Wall St. Rank held Amgen as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.